Iron metabolism in patients with Graves' hyperthyroidism.

Area of Science:

• Endocrinology
• Iron Metabolism
• Molecular Biology

Background:

• Graves' hyperthyroidism (GH) impacts iron metabolism and ferritin levels.
• Mechanisms linking GH, iron, and hepcidin regulation are not fully understood.
• Thyroid hormone effects on hepcidin synthesis and regulation require characterization.

Purpose of the Study:

• To investigate the influence of thyroid hormones on hepcidin, a key regulator of iron metabolism.
• To elucidate the mechanisms by which Graves' hyperthyroidism affects iron metabolism.
• To assess changes in iron metabolism parameters and inflammatory markers in GH patients.

Main Methods:

• Prospective observational study of 31 patients with new-onset, untreated Graves' hyperthyroidism.
• Assessed iron metabolism (ferritin, transferrin, hepcidin), inflammatory markers, and cytokines at diagnosis (T0) and euthyroidism (T1).
• Measured hepcidin using mass spectrometry (hepcidinMS) and ELISA (hepcidinEL); studied T3's impact on hepatic hepcidin expression in HepG2 cells.

Main Results:

• Ferritin levels decreased and transferrin increased significantly from T0 to T1.
• HepcidinMS levels were lower at T1 (significant in males), while hepcidinEL showed no significant difference.
• T3 significantly induced hepcidin mRNA expression in HepG2 cells; inflammatory markers remained unchanged.

Conclusions:

• Iron metabolism in Graves' hyperthyroidism exhibits dynamic changes resembling an acute-phase reaction.
• Thyroid status did not affect inflammatory parameters or cytokines.
• Gender and smoking status influenced ferritin, hepcidin, and thyroid hormone levels.